Direxion Daily S&P Biotech Bear 3X ETF
LABD
13 hedge funds and large institutions have $22.8M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
264% more call options, than puts
Call options by funds: $36.8M | Put options by funds: $10.1M
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
66% more capital invested
Capital invested by funds: $13.8M → $22.8M (+$9.08M)
18% more funds holding
Funds holding: 11 → 13 (+2)
0.03% more ownership
Funds ownership: 0.08% → 0.11% (+0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.63M |
| 2 |
HF
HRT Financial
New York
|
+$1.54M |
| 3 |
IMC Chicago
Chicago,
Illinois
|
+$910K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$799K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$445K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$1.17M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$646K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$346K |
| 4 |
Morgan Stanley
New York
|
-$333K |
| 5 |
VF
Virtu Financial
New York
|
-$232K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $10.6M | -$333K | -81 | -4% |
|
|
2
Jane Street
New York
| $3.87M | +$1.63M | +396 | +108% |
|
|
HF
3
HRT Financial
New York
| $2.32M | +$1.54M | +375 | +452% |
|
|
BG
4
Bellevue Group
Kuesnacht,
Switzerland
| $1.39M | -$1.17M | -285 | -51% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1.37M | +$445K | +108 | +66% |
|
|
6
IMC Chicago
Chicago,
Illinois
| $1.12M | +$910K | +221 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $1.09M | +$799K | +194 | +882% |
|
|
8
Simplex Trading
Chicago,
Illinois
| $478K | -$346K | -84 | -47% |
|
|
XS
9
XR Securities
Chicago,
Illinois
| $225K | +$181K | +44 | New |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| $167K | – | – | – |
|
11
UBS Group
Zurich,
Switzerland
| $76K | +$28.8K | +7 | +88% |
|
12
Citigroup
New York
| $67K | +$53.5K | +13 | New |
|
|
CG
13
Cutler Group
San Francisco,
California
| $17K | +$16.5K | +4 | New |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$646K | -157 | Closed |
|
|
VF
15
Virtu Financial
New York
| – | -$232K | -64 | Closed |
|
LABD Hedge Fund Activity: Q3 2019 in Review
13 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q3 2019, worth a combined $22.8M — up 66% from $13.8M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new LABD positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Jane Street, adding an estimated $1.63M. The largest seller was Bellevue Group, cutting an estimated $1.17M.
- 13 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q3 2019, up from 11 in Q2 2019.
- Funds reported $22.8M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q3 2019, up 66% quarter-over-quarter.
- 4 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q3 2019 and 2 closed out, a net change of +2 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q3 2019 was Jane Street, an estimated $1.63M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q3 2019 was Bellevue Group, an estimated $1.17M sold.
Based on aggregated 13F filings for Q3 2019.